Another study based on miRNA/SNCA regulation on an MPP treated SH-SY5Y cell model that aimed to delineate the mechanism of pramipexole administration in PD patients showed a downregulation of circSNCA and SNCA expression post pramipexole treatment. The gene discussed is SNCA; the disease is Parkinson disease.